Biocon Company Description

Biocon Limited, together with its subsidiaries, engages in the manufacture and sale of biotechnology products and research services in India, Brazil, Singapore, and internationally.

It operates through four segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company offers generic formulations and API products, including anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology, and other products; novel biologics products, such as head and neck cancer molecule; novel pipeline products comprising psoriasis molecules; and biosimilars products consisting of insulins, trastuzumab, pegfilgrastim, and bevacizumab.

It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer good, and agrochemical companies.

Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.

Biocon Limited

Country	India
Founded	1978
Industry	Biotechnology
Sector	Healthcare
Employees	16,315
CEO	Siddharth Mittal

Contact Details

Address: 20th KM Hosur Road Bengaluru, Karnataka 560100 India
Phone	91 80 2808 2808
Website	biocon.com

Stock Details

Ticker Symbol	BIOCON
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
ISIN Number	INE376G01013
SIC Code	2836

Key Executives

Name	Position
Peter James Jonathan Bains	Group Chief Executive Officer
Siddharth Mittal BCom, CA, CPA	MD, Chief Executive Officer and Director
Mukesh Kamath	Chief Financial Officer
Arun Gupta	Head of Operations
Atanu Roy	Group Chief Information Officer
Saurabh Paliwal	Head of Investor Relations
Mayank Verma	Company Secretary and Compliance Officer
Seema Shah Ahuja BA, MBA	Global Head of Communications and Corporate Brand
Maninder Kapoor Puri	Head of Human Resources
Paul Vazhayil Thomas	Chief Commercial Officer, U.S. and Portfolio Strategy & Business Dev, Adv mkts of Biosimilars Business